The US embolization coil market is expected to show a progressive increase in revenue from 2020 through 2035. Valued at approximately $613 million in 2025, continuous investment in R&D, a growing number of minimally invasive procedures, and robust healthcare spending are anticipated to support further expansion. As hospitals and clinics continue to adopt advanced embolization technologies, revenue is forecasted to surpass $1,120 million by 2035, underlining a strong compound annual growth rate throughout the period.
Read More - https://bussinessinsights.com/research-report/us-embolization-coil
Neurology applications are projected to represent the largest share of the US embolization coil market in 2025. This is attributed to the increasing incidence of cerebral aneurysms and the expanded adoption of minimally invasive embolization techniques for neurovascular intervention. Oncology follows closely, reflecting rising use in tumor embolization procedures. Cardiology accounts for substantial market activity, supported by ongoing advancements in coil design and tailored cardiovascular solutions. Diversification into urology and peripheral vascular interventions continues to expand end-user adoption.
Request Free Sample- https://bussinessinsights.com/request/medical-devices/us-embolization-coil
Who are the key players in US Embolization Coil industry?
Key players in the US Embolization Coil industry include Boston Scientific, Medtronic, Terumo Corporation, Stryker Corporation, and Cook Medical. These companies drive innovation through extensive R&D, robust distribution networks, and comprehensive product portfolios, maintaining significant market presence and credibility within the vascular and interventional radiology sectors.
What is the US Embolization Coil growth?
The US Embolization Coil market has seen consistent growth, particularly due to the rising incidence of aneurysms and vascular malformations. For instance, Boston Scientific reported increased demand for its embolization products in 2023, propelled by new technology adoption and expanding minimally invasive procedures.
Which segment accounted for the largest US Embolization Coil share?
The neurovascular embolization segment holds the largest market share. This is mainly driven by the prevalence of brain aneurysms and stroke treatment advancements. Technologies designed for minimally invasive brain procedures, like those offered by Medtronic, have significantly expanded application in neurovascular interventions.
Thanks & Regards,
Manisha C
sales [at] bussinessinsights.com